Sagimet Biosciences Inc.

SGMT

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 05/12/2026FY2026 Q1

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-11M USD

YoY Reduced Deficit

Equity Ratio

95.1%

YoY -0.0pt

BPS

3.15$

YoY -27.1%

Revenue

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

Actual

YoY$0 (-)

Net Income

$-10.7M

FY2024 Q2$-14.7M

$-14.7M

FY2024 Q3$-29.4M

$-29.4M

Surprise History

Actual RevenueAnalyst Estimate

FY2020

Actual:$0

FY2020

FY2021